| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Pakianathan Deepika is a Director at MREO, with reported holdings spanning 4 companies. Recent filings cover 2 purchases and 21 sales. Those positions are worth an estimated $407K at current prices.
Our model assigns Pakianathan Deepika a strong insider score of 90/100, based on 10 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +67.0%.
Pakianathan Deepika's largest disclosed position is in MREO as Director, worth about $407K. The recent filings there lean toward selling, a net 105,244 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2024 | MREO Mereo Biopharma Group Plc | Director | Sale+OE | 105,244 | $4.43 | $466,209.87 | -100% | -20.6% | -62.3% | |
| Jun 7, 2024 | KPTI Karyopharm Therapeutics Inc. | Director | Sell | 818,044 | $0.96 | $785,027.07 | -100% | -16.9% | -68.8% | |
| Jun 4, 2024 | KPTI Karyopharm Therapeutics Inc. | Director | Sell | 906,178 | $0.97 | $880,692.58 | -99.1% | -22.3% | -68.8% | |
| Jan 27, 2023 | Director | Sell | 121,333 | $0.39 | $46,810.27 | -100% | - | - | ||
| Jun 10, 2022 | KPTI Karyopharm Therapeutics Inc. | Director | Sell | 538,784 | $6.38 | $3,434,798.41 | -97.0% | -2.4% | -59.8% | |
| Jan 12, 2015 | KPTI Karyopharm Therapeutics Inc. | Director | Buy | 45,454 | $33.00 | $1,499,982.00 | -192.8% | - | - |